Fungal strain Beauveria sp. MTCC 5184 and a process for the preparation of enzymes therefrom
US-9217140-B2 · Dec 22, 2015 · US
US9394530B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9394530-B2 |
| Application number | US-201314372858-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 25, 2013 |
| Priority date | Feb 3, 2012 |
| Publication date | Jul 19, 2016 |
| Grant date | Jul 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to lipase variants and methods of obtaining them. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Opening claim text (preview).
The invention claimed is: 1. A lipase variant, comprising a substitution G91Q corresponding to the position of the mature polypeptide of SEQ ID NO: 2, wherein the variant has at least 90% sequence identity to the mature polypeptide of SEQ ID NO: 2, and has lipase activity. 2. The variant of claim 1 , which has at least 95% sequence identity to the amino acid sequence of the parent lipase. 3. The variant of claim 1 , which has at least 97% sequence identity to the amino acid sequence of the parent lipase. 4. The variant of claim 1 , which has at least 98% sequence identity to the amino acid sequence of the parent lipase. 5. The variant of claim 1 , which further comprises a substitution at one or more positions corresponding to positions D96, T143, A150, E210, G225, T231, N233 and P250. 6. The variant of claim 5 , wherein the substitution comprises one or more of D96G, T143A, A150G, E210Q, G225R, T231R, N233R and P250R. 7. The variant of claim 1 , wherein said variant comprises the following substitutions: a) G91Q +T143A +E210Q +T231R +N233R +P250R; b) G91Q +A150G +E210Q +T231R +N233R +P250R; or c) G91Q +E210Q +T231R +N233R +P250R. 8. The variant of claim 1 , which in comparison with the parent lipase has improved performance in the presence of an organic catalyst selected from the group consisting of organic catalysts having the following formulae: a) b) or c) mixtures thereof, wherein each R1 is independently a branched alkyl group containing from 3 to 24 carbons or a linear alkyl group containing from 1 to 24 carbons; and recovering the variant. 9. The variant of claim 8 , wherein R1 is independently selected from the group consisting of 2-propylheptyl, 2-butyloctyl, 2-pentylnonyl, 2-hexyldecyl, n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, iso-nonyl, iso-decyl, iso-tridecyl, and iso-pantadecyl.
containing lipase · CPC title
Triglyceride splitting, e.g. by means of lipase · CPC title
Carboxylic ester hydrolases {(3.1.1)} · CPC title
Carboxylic ester hydrolases (3.1.1) · CPC title
Heterocyclic compounds, e.g. cyclic imides or lactames · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.